Top compounds associated with response to C5orf42


Feature Type Standardized
Nominal ANOVA
mRNA tigecycline CTRPv2 pan-cancer AAC 0.001 1
mRNA OSI-027 GDSC1000 pan-cancer AAC -0.00062 1
mRNA Cetuximab GDSC1000 pan-cancer AAC 0.00064 1
mRNA BRD-K16147474 CTRPv2 pan-cancer AAC 0.00075 1
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.00061 1
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.00067 1
mRNA TKI258 CCLE pan-cancer AAC -0.00076 1
mRNA nintedanib CTRPv2 pan-cancer AAC 0.00056 1
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.00043 1
mRNA Methotrexate GDSC1000 pan-cancer AAC -0.00033 1
Download CSV